INDIANAPOLIS--(EON: Enhanced Online News)--Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced publishing seven new volumes of New and Future Developments in Catalysis edited by Steven Suib. These will be first presented here in Indianapolis at Chemistry in Motion, the American Chemical Society’s annual meeting held September 8-12.
The seven volumes compile the latest ideas regarding biofuels and the production of chemicals with less damage to the environment, as well as a comprehensive summary of past, current, and future research on efficient, sustainable and clean catalytic processes. Editor Steven Suib is a leader in solid-state catalysis and renewable energy systems in the US with 450 articles and 40 patents to his name. He has also authored multiple books on the topic of catalysis and serves as an editor for Elsevier journal Microporous and Mesoporous Materials.
The full titles of the seven new volumes are:
All titles listed above are available through the Elsevier Store or can be found on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than 2,500 peer-reviewed journals and almost 20,000 book titles.
This week Elsevier also launched a Chemical Reaction Books Portfolio on ScienceDirect. The custom-curated online portfolio includes 474 books with foundational and applied content across three sub-disciplines: chemistry and polymers; oil and gas; and pharmaceuticals and biotechnology. Handpicked by pharmaceutical and biotechnology editors from Elsevier and Reaxys, it offers chemists and business stakeholders technical, economic and commercial resources to lead research and development, while maximizing productivity, efficiency and discovery.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.